India offers free access to 45 cancer drugs and insulin for impoverished patients

20 October 2023

Even as India's National Pharmaceutical Pricing Authority (NPPA) is currently deliberating a threshold price for 10 formulations, including a significant 70% price reduction for a brain cancer drug, poor patients at the AIIMS hospital in Delhi are to get 63 more drugs, including 45 cancer drugs for free.

Among the medicines to be disbursed for free are palbociclib, tamoxifen, cyclophosphamide and anastrozole (for treating breast cancer), imatinib and dasatinib (for blood cancer), temozolomide (for specific types of brain cancer), sorafenib (for liver carcinoma), capecitabine (for gallbladder cancer) and methotrexate, trimazet (to treat heart disease), megestrol acetate and leucovorin as well as some insulin injections.

Expanded AIIMS list

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK